New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 4, 2013
13:48 EDTNPSP, NIHD, MLNXOptions with decreasing option implied volatility; MLNX NIHD NUS NPSP
News For MLNX;NIHD;NPSP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
08:00 EDTMLNXMellanox price target raised to $63 from $53 at Stifel
Stifel increased its price target on Mellanox after the company reported stronger than expected Q4 results. The firm expects the company to benefit from an ongoing data center upgrade cycle well into 2016, and keeps a Buy rating on the shares.
06:18 EDTMLNXMellanox filed revised financial statements to correct errors in FY11-FY13
Subscribe for More Information
January 28, 2015
18:21 EDTMLNXOn The Fly: After Hours Movers
Subscribe for More Information
16:13 EDTMLNXMellanox sees Q1 revenue $140M-$145M, consensus $135.36M
Subscribe for More Information
16:12 EDTMLNXMellanox reports Q4 EPS 59c, consensus 44c
Subscribe for More Information
January 27, 2015
10:00 EDTMLNXOn the Fly: Analyst Downgrade Summary
Subscribe for More Information
06:00 EDTNPSPStocks with implied volatility below IV index mean; ORCL NPSP
Stocks with implied volatility below IV index mean; Oracle (ORCL) 17, NPS Pharmaceuticals (NPSP) 2 according to iVolatility.
05:03 EDTMLNXMellanox downgraded to Hold from Buy at Jefferies
Jefferies downgraded Mellanox to Hold citing limited upside potential to its $50 price target.
January 26, 2015
10:19 EDTNPSPHigh option volume stocks
High option volume stocks: OIL NFX ABB FXCM SANM EL MAT AGO NPSP SSTK
08:21 EDTNPSPShire the 'real winner' after NPS gets approval for Natpara, says Janney Capital
Janney Capital said NPS Pharmaceuticals' (NPSP) getting FDA approval for its second marketed product, Natpara, is a positive for NPS, but that the "real winner" is Shire (SHPG), noting that the company had no stipulations dependent on Natpara approval in its deal to buy NPS. The firm expects the acquisition to move forward as planned and maintains its Neutral rating on NPS shares.
07:27 EDTNPSPShire price target raised to $263 from $247 at Jefferies
Subscribe for More Information
January 25, 2015
12:30 EDTNPSPShire comments on press release from NPS Pharma on Natpara approval
Subscribe for More Information
January 23, 2015
19:15 EDTNPSPNPS Pharmaceuticals announces FDA approval of Natpara
Subscribe for More Information
January 20, 2015
10:20 EDTNPSPOptions with decreasing implied volatility
Options with decreasing implied volatility: RPRX TLM BBY GME CBST NPSP

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use